博文
Oncogene：首个靶向膜联蛋白A1的药物被证实有效
||
Oncogene：首个靶向膜联蛋白A1的药物被证实有效
https://www.ebiotrade.com/newsf/2024-1/20240120020300968.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=11c3592f-be64-4e1e-828c-3a624cf34f2f
| 01. | Humans | 33 篇 | 51.563% |
| 02. | Annexin A1 | 29 篇 | 45.313% |
| 03. | Animals | 27 篇 | 42.188% |
| 04. | Mice | 19 篇 | 29.688% |
| 05. | Peptides | 8 篇 | 12.500% |
| 06. | Cell Line, Tumor | 6 篇 | 9.375% |
| 07. | Female | 6 篇 | 9.375% |
| 08. | Inflammation | 5 篇 | 7.813% |
| 09. | Rats | 5 篇 | 7.813% |
| 10. | Signal Transduction | 5 篇 | 7.813% |
https://fx.wanfangdata.com.cn/keytrends/detail?theme_name=annexin-A1
https://kns.cnki.net/kns8s/search?classid=WD0FTY92&kw=annexin-A1&korder=SU
(68)
(61)
(59)
(15)
(9)
(9)
(7)
(7)
(6)
(5)
(5)
(5)
(5)
(5)
(5)
(4)
(4)
(4)
(4)
(4)
http://www.pubmedplus.cn/P/SearchQuickResult?wd=3b337bf0-6cfe-470d-b383-a795d47f4093
1. A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo.
Anglia Ruskin University, School of Life Science, Faculty of Science and Engineering, East Road, Cambridge, CB1 1PT, UK.
Chris.parris@aru.ac.uk
Oncogene (P 1476-5594 E 0950-9232) H指数：312 2024 年
PMID：38200229 相似文献
文摘 DOI链接 
Nature Publishing Group
| 01. | Annexin A1 | 85 篇 | 84.158% |
| 02. | Humans | 71 篇 | 70.297% |
| 03. | Animals | 42 篇 | 41.584% |
| 04. | Female | 36 篇 | 35.644% |
| 05. | Mice | 35 篇 | 34.653% |
| 06. | Cell Line, Tumor | 33 篇 | 32.673% |
| 07. | Male | 30 篇 | 29.703% |
| 08. | Receptors, Formyl Peptide | 28 篇 | 27.723% |
| 09. | Cell Movement | 27 篇 | 26.733% |
| 10. | Cell Proliferation | 25 篇 | 24.752% |
https://wap.sciencenet.cn/blog-280034-1419053.html
上一篇：Science：提高液体癌活检的敏感性和成功率
下一篇：Cell Stem Cell：SARS-CoV-2可以感染多巴胺神经元，导致衰老
